What It Targets Our Epithalon peptide is designed to target: Telomere attrition and genomic instability, key hallmarks of biological aging that correlate with agerelated disease risk. Agerelated decline in melatonin production and circadian rhythm amplitude that affects sleep quality, mood, and hormonal balance. Biomarkers and symptoms of aging such as reduced recovery, low resilience to stress, and tired but wired sleep patterns in midlife and beyond. Clients already focused on longevity who want to explore precision protocols that connect peptides, telomere testing, and lifestyle design
The Appropriate Conclusion The existence of limited human reports means BPC-157 is not entirely absent from human literature
GHK-Cu acts as a potent chemoattractant for macrophages, mast cells, and capillary endothelial cells[18]
Great product, great service
Most evidence so far is preclinical (cells/animals), but the story is consistent: free up resources systems run smoother